Computational toxicology, friend or foe?
暂无分享,去创建一个
[1] Gabriele Cruciani,et al. Modeling Phospholipidosis Induction: Reliability and Warnings , 2013, J. Chem. Inf. Model..
[2] David M. Reif,et al. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. , 2014, Current opinion in pharmacology.
[3] Dominic P. Williams,et al. Toxicophores: investigations in drug safety. , 2006, Toxicology.
[4] Robert J Kavlock,et al. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.
[5] K. Houck,et al. An evaluation of 25 selected ToxCast chemicals in medium‐throughput assays to detect genotoxicity , 2015, Environmental and molecular mutagenesis.
[6] Russell O. Potts,et al. Predicting Skin Permeability , 1992, Pharmaceutical Research.
[7] H. Yamada,et al. The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.
[8] Naomi L Kruhlak,et al. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals. , 2007, Regulatory toxicology and pharmacology : RTP.
[9] Weida Tong,et al. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[10] J. Hughes,et al. Physiochemical drug properties associated with in vivo toxicological outcomes. , 2008, Bioorganic & medicinal chemistry letters.
[11] Daniela Schuster,et al. In silico methods in the discovery of endocrine disrupting chemicals , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[12] Errol Zeiger,et al. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity. , 2009, Mutagenesis.
[13] Kunal Roy,et al. Development of classification and regression based QSAR models to predict rodent carcinogenic potency using oral slope factor. , 2012, Ecotoxicology and environmental safety.
[14] Irini A. Doytchinova,et al. Quantitative structure--clearance relationships of acidic drugs. , 2013, Molecular pharmaceutics.
[15] C. Elangbam,et al. Drug-induced Valvulopathy: An Update , 2010, Toxicologic pathology.
[16] Gilles Klopman,et al. Benchmark Performance of MultiCASE Inc. Software in Ames Mutagenicity Set , 2010, J. Chem. Inf. Model..
[17] Melvin E. Andersen,et al. Modeling Drug- and Chemical-Induced Hepatotoxicity with Systems Biology Approaches , 2012, Front. Physio..
[18] Anne Hersey,et al. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. , 2006, Journal of medicinal chemistry.
[19] Nigel Greene,et al. Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies. , 2010, Bioorganic & medicinal chemistry letters.
[20] Michael P Holt,et al. Mechanisms of drug-induced liver injury , 2006, The AAPS Journal.
[21] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[22] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[23] R. Elton,et al. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds , 2005, Occupational and Environmental Medicine.
[24] Ovanes Mekenyan,et al. A mechanistic approach to modeling respiratory sensitization. , 2014, Chemical research in toxicology.
[25] E. Zeiger,et al. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals , 1988, Environmental and molecular mutagenesis.
[26] Jeffrey J Sutherland,et al. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes. , 2012, Journal of medicinal chemistry.
[27] Nigel Greene,et al. Latest advances in computational genotoxicity prediction , 2012, Expert opinion on drug metabolism & toxicology.
[28] M T D Cronin,et al. Development of mechanism-based structural alerts for respiratory sensitization hazard identification. , 2012, Chemical research in toxicology.
[29] Andrew G. Garrow,et al. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries. , 2012, Drug discovery today.
[30] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[31] George Daston,et al. Framework for identifying chemicals with structural features associated with the potential to act as developmental or reproductive toxicants. , 2013, Chemical research in toxicology.
[32] Luis G Valerio,et al. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities. , 2012, Toxicology and applied pharmacology.
[33] Mark T D Cronin,et al. The Use of a Chemistry-based Profiler for Covalent DNA Binding in the Development of Chemical Categories for Read-across for Genotoxicity , 2011, Alternatives to laboratory animals : ATLA.
[34] R. Elton,et al. Occupational asthma and the chemical properties of low molecular weight organic substances. , 1994, Occupational medicine.
[35] J. Talwalkar,et al. Drug-induced liver injury. , 2014, Mayo Clinic proceedings.
[36] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[37] Ulf Norinder,et al. In silico categorization of in vivo intrinsic clearance using machine learning. , 2013, Molecular pharmaceutics.
[38] David M. Reif,et al. In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.
[39] A. Robertson,et al. Structure activity hypotheses in occupational asthma caused by low molecular weight substances. , 1991, The Annals of occupational hygiene.
[40] E. Zeiger,et al. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.
[41] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[42] Ralph Kühne,et al. Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses , 2010, Molecular Diversity.
[43] H. Rosenkranz,et al. Structure-activity model of chemicals that cause human respiratory sensitization. , 1997, Regulatory toxicology and pharmacology : RTP.
[44] Alessandro Giuliani,et al. Putting the Predictive Toxicology Challenge Into Perspective: Reflections on the Results , 2003, Bioinform..
[45] Edward H. Kerns,et al. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery , 2010, Nature Reviews Drug Discovery.
[46] T. Singer,et al. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations. , 2011, Chemical research in toxicology.
[47] Neil Kaplowitz,et al. Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.
[48] Nigel Greene,et al. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey. , 2012, Regulatory toxicology and pharmacology : RTP.
[49] Tudor I. Oprea,et al. The significance of acid/base properties in drug discovery. , 2013, Chemical Society reviews.
[50] Nigel Greene,et al. Physicochemical drug properties associated with in vivo toxicological outcomes: a review , 2009, Expert opinion on drug metabolism & toxicology.
[51] Carol A Marchant,et al. In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic , 2008, Toxicology mechanisms and methods.
[52] J C Lindon,et al. A QSAR investigation of dermal and respiratory chemical sensitizers based on computational chemistry properties , 2009, SAR and QSAR in environmental research.
[53] Kellyn S. Betts,et al. Tox21 to Date: Steps toward Modernizing Human Hazard Characterization , 2013, Environmental health perspectives.
[54] Nigel Greene,et al. The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[55] Judith C. Madden,et al. Assessment of Methods To Define the Applicability Domain of Structural Alert Models , 2011, J. Chem. Inf. Model..
[56] Andreas Hartmann,et al. Towards the creation of an international toxicology information centre. , 2005, Toxicology.
[57] Lutz Müller,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.
[58] Jiri Aubrecht,et al. Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies. , 2010, Toxicology letters.
[59] G. Williams,et al. The hepatocyte primary culture/DNA repair assay using mouse or hamster hepatocytes. , 1983, Environmental mutagenesis.
[60] O. Engkvist,et al. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. , 2012, Journal of medicinal chemistry.
[61] T. Schroeter,et al. Target promiscuity and physicochemical properties contribute to pharmacologically induced ER-stress. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[62] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[63] R. Tennant,et al. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.
[64] Horvath Dragos,et al. Predicting the predictability: a unified approach to the applicability domain problem of QSAR models. , 2009, Journal of chemical information and modeling.
[65] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[66] Ferran Sanz,et al. The eTOX Data-Sharing Project to Advance in Silico Drug-Induced Toxicity Prediction , 2014, International journal of molecular sciences.
[67] A. Worth,et al. Q)SARs for Predicting Effects Relating to Reproductive Toxicity , 2008 .
[68] Ronald D Snyder,et al. Assessment of atypical DNA intercalating agents in biological and in silico systems. , 2007, Mutation research.
[69] Franco Lombardo,et al. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. , 2002, Journal of medicinal chemistry.
[70] C. Elangbam,et al. 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats. , 2008, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[71] E. Zeiger,et al. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. , 1987, Environmental mutagenesis.
[72] Scott Boyer,et al. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. , 2013, Regulatory toxicology and pharmacology : RTP.
[73] Nigel Greene,et al. Developing structure-activity relationships for the prediction of hepatotoxicity. , 2010, Chemical research in toxicology.
[74] Vijay K. Gombar,et al. Quantitative Structure − Activity Relationship Models of Clinical Pharmacokinetics : Clearance and Volume of Distribution , 2013 .
[75] Nigel Greene,et al. The computational prediction of genotoxicity , 2010, Expert opinion on drug metabolism & toxicology.
[76] Nigel Greene,et al. Comparing Measures of Promiscuity and Exploring Their Relationship to Toxicity , 2012, Molecular informatics.
[77] A. Stepan,et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.
[78] Alessandro Giuliani,et al. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays , 2010, Expert opinion on drug metabolism & toxicology.
[79] M. Hewitt,et al. Chapter 12:Developing the Applicability Domain of In Silico Models: Relevance, Importance and Methods , 2010 .
[80] Jiri Aubrecht,et al. New and emerging technologies for genetic toxicity testing , 2011, Environmental and molecular mutagenesis.
[81] K R Przybylak,et al. Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action , 2013, Critical reviews in toxicology.
[82] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[83] D. Basketter,et al. In vitro approaches to the identification and characterization of skin sensitizers. , 2013, Cutaneous and ocular toxicology.
[84] Ralph Kühne,et al. Chemical Domain of QSAR Models from Atom-Centered Fragments , 2009, J. Chem. Inf. Model..
[85] Nina Nikolova-Jeliazkova,et al. QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review , 2005, Alternatives to laboratory animals : ATLA.
[86] E. Zeiger,et al. Salmonella mutagenicity test results for 250 chemicals. , 1983, Environmental mutagenesis.
[87] Nicholas Ball,et al. Use of category approaches, read-across and (Q)SAR: general considerations. , 2013, Regulatory toxicology and pharmacology : RTP.